Skip Navigation



Japanese Journal of Clinical Oncology Advance Access published online on February 14, 2006

Japanese Journal of Clinical Oncology, doi:10.1093/jjco/hyi233
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
36/3/166    most recent
hyi233v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Mutoh, M.
Right arrow Articles by Wakabayashi, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mutoh, M.
Right arrow Articles by Wakabayashi, K.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2006 Foundation for Promotion of Cancer Research
Received September 7, 2005
Accepted December 19, 2005

Original Article

Possible Involvement of Hyperlipidemia in Increasing Risk of Colorectal Tumor Development in Human Familial Adenomatous Polyposis

Michihiro Mutoh 1 *, Takayuki Akasu 2, Mami Takahashi 1, Naoko Niho 1, Teruhiko Yoshida 3, Takashi Sugimura 1, and Keiji Wakabayashi 1

1 Cancer Prevention Basic Research Project, National Cancer Center Research Institute, Tokyo, Japan
2 Department of Surgery, National Cancer Center Hospital, Tokyo, Japan
3 Genetics Division, National Cancer Center Research Institute, Tokyo, Japan

* To whom correspondence should be addressed.
Michihiro Mutoh, E-mail: mimutoh{at}gan2.ncc.go.jp


   Abstract

Background: Familial adenomatous polyposis (FAP) results from germline adenomatous polyposis coli (APC) gene mutations and many affected patients die from colorectal cancers which arise from colorectal polyps. We previously reported that two strains of Apc gene-deficient mice developing multiple intestinal polyps exhibit a hyperlipidemic state. The triglyceride (TG) levels were ~10-fold higher than the levels observed in wild-type mice.

Methods: To examine whether a positive relationship might exist between hyperlipidemia and colorectal tumor development in FAP patients, as with Apc gene-deficient mice, a pilot experiment was performed using readily available clinical data such as ages, serum lipid levels, number of colorectal polyps and cancer development in 28 FAP patients from the National Cancer Center Hospital, Japan.

Results: The overall prevalence of hyperlipidemia in FAP cases was 58%. Average TG levels in the 40-60 year age groups of FAP patients were ≥150 mg/dl (the defined threshold level of hyperlipidemia). Moreover, there was a tendency for higher serum TG levels in patients who developed colorectal cancer, as compared with those without colorectal cancer.

Conclusions: These results show that a hyperlipidemic state occurs in FAP patients. Although it is weaker than that in Apc gene-deficient mice, it may be linked to colon tumor development. These data warrant further studies for wider poplulations of FAP patients.

Keywords: APC gene; colorectal cancer; familial adenomatous polyposis; hyperlipidemia.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
K. N. Ealey, S. Lu, D. Lau, and M. C. Archer
Reduced susceptibility of muscle-specific insulin receptor knockout mice to colon carcinogenesis
Am J Physiol Gastrointest Liver Physiol, March 1, 2008; 294(3): G679 - G686.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.